WisdomTree BioRevolution Fund (WDNA)

BATS: WDNA · Real-Time Price · USD

17.28

-0.43 (-2.45%)

May 15, 2026, 4:00 PM EDT - Market closed

-2.45% (1D)

Assets	$2.24M
Expense Ratio	0.45%
PE Ratio	21.41
Shares Out	130,000
Dividend (ttm)	$0.77
Dividend Yield	4.46%
Ex-Dividend Date	Dec 26, 2025
Payout Frequency	Annual
Payout Ratio	92.22%

Volume	344
Open	17.64
Previous Close	17.71
Day's Range	17.28 - 17.64
52-Week Low	12.04
52-Week High	18.88
Beta	1.01
Holdings	80
Inception Date	Jun 3, 2021

About WDNA

Fund Home Page

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is issued by WisdomTree.

Asset Class Equity

Category Health

Stock Exchange BATS

Ticker Symbol WDNA

ETF Provider WisdomTree

Index Tracked WisdomTree BioRevolution Index

Top 10 Holdings

29.19% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	3.98%
Twist Bioscience Corporation	TWST	3.56%
Moderna, Inc.	MRNA	3.45%
Johnson & Johnson	JNJ	3.14%
United Therapeutics Corporation	UTHR	3.03%
Immunome, Inc.	IMNM	2.73%
Darling Ingredients Inc.	DAR	2.59%
Stoke Therapeutics, Inc.	STOK	2.33%
Corteva, Inc.	CTVA	2.28%
Beam Therapeutics Inc.	BEAM	2.09%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$0.77052	Dec 30, 2025
Dec 26, 2024	$0.1071	Dec 30, 2024
Dec 22, 2023	$0.135	Dec 28, 2023
Dec 23, 2022	$0.06526	Dec 29, 2022
Dec 27, 2021	$0.02458	Dec 30, 2021

Full Dividend History

Performance

WDNA had a total return of 50.59% in the past year, including dividends. Since the fund's inception, the average annual return has been -5.91%.